Clinical Trial: A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199504) titled 'A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole' on Sept. 22.

Brief Summary: The purpose of this clinical trial is to determine whether dipyridamole can treat restless legs syndrome in patients with uremia. It will also evaluate the safety of dipyridamole. The main questions it aims to answer are: Does dipyridamole improve the symptoms of restless legs syndrome in participants? Can dipyridamole improve participants' anxiety, depression, sleep quality, and quality of life? What adverse reactions occur in participants while taking dipyridamole? This study is a self-controlled study, with a...